Introduction and objectives: A large proportion of patients with coronary disease have metabolic syndrome. The purpose of this research was to assess the association between the metabolic syndrome (MetS) and acute myocardial infarction in female patients.
Introduction
Cough is the most important clinical symptom of respiratory disease. Patients with trivial viral respiratory tract infection to life threatening bronchial carcinoma may all present with simple cough. Sometimes cough is the only symptom of many respiratory diseases.
Non-specific chronic cough may be defined as a cough with duration of 3 weeks or more without any fever or systemic illness and where chest xray, sputum for AFB (3 samples) and spirometry are inconclusive 1 .
The metabolic syndrome prevalence is increasing worldwide and is a serious public health problem.
It is a combination of interrelated metabolic abnormalities that significantly increase the risk of cardiovascular disease, and type 2 diabetes mellitus (DM2) [1] [2] [3] [4] [5] [6] . In general population the prevalence studies in different countries showed differing proportion ranging from as low as 2.5% to as high as 58% with propensity towards older age for its consequences on diabetes and cardiovascular diseases 7, 8 . In Bangladesh, studies on hypertension, diabetes 9 and dyslipidemia 10 assessed rising prevalence. There are also prevalence studies of metabolic syndrome in rural Bangladeshi women 11 . In the population of Bangladeshi women MetS was presented in 25.6% respondents and it was more prevalent among post-menopausal (39.3%) as compared to pre menopausal (16.8%) women 11 . Another study conducted by Subrina Jesmine 12 et al. revealed that the prevalence rates of MetS in rural Bangladeshi women were 25.6% (NCEP ATP III), 36.68% (modified NCEP ATP III). Furthermore, 29.9% had elevated blood pressure, 30.42 % had elevated fasting plasma glucose and 85.4% had low HDL-C and 26.91% had increased triglyceride values 13 . Prevalence of elevated fasting blood glucose and high trigyceride were significantly higher in post menopausal women than premenopausal women 14 . Among the acute myocardial infarction patients, the metabolic syndrome was 46% and the patients with metabolic syndrome were older and more likely to be women 12 . In another study on acute myocardial infarction, conducted by Tariq Ashraf et al. showed that frequency of MetS was seen high in females as compared to males (54.9% in males and 78.7% in females) 15 . Some studies have analyzed the prevalence of MetS in patients with acute coronary disease, reporting an estimated prevalence of 41%-50% in Europe and the United States 16, 17 . Many studies revealed that each component of MetS is individually associated with an increased risk of cardiovascular disease; however, whether MetS leads to greater cardiovascular risk than the sum of its components remains a matter of debate 18 .
Methods

Study Population:
Clinical histories from patients with acute myocardial infarction admitted to coronary care unit of Rajshahi Medical College Hospital, Rajshahi, Bangladesh were selected. In total, 206 patients were included in the analysis. Female patients with acute myocardial infarction were 103 as cases and male patients with acute myocardial infarction were 103 as control.
Definition of Variables:
Demographic and clinical data were obtained from the clinical histories: age, sex, weight, height, smoking, alcohol consumption, and previous lipidlowering treatment. Fasting plasma glucose levels and lipid profile (HDL-C, and triglycerides) were measured. The diagnosis of MetS was established using modified ATPIII criteria 2 based on the presence of 3 or more of the following 5 factors: a) waist circumference for Asia-Pacific as ≥ 90 cm for men and ≥ 80 cm, b) hypertension, defined as clinical history of documented elevated blood pressure or persistent systolic blood pressure ≥ 130/≥85 mmHg, c) hypertriglyceridemia, defined as fasting plasma triglyceride levels >150 mg/dL previous to or within 24 h of admission; d) low plasma HDLc values, defined as < 40 mg/dL (1.04 mmol/L) for men and < 50 mg/dL (1.3 mmol/L) for women, measured either before or within the first 24 h of admission, and e) carbohydrate metabolism disorder, defined as previously documented impaired fasting plasma glucose levels or a history of DM2 or fasting plasma glucose levels >110 mg/dL (≥6.1 mmol/L) at least 48 h after admission.
Results
Total 103 female patients were evaluated. Age of the female patients was shown in Table 1 . Mean age was 54.28 ±11.78 and acute myocardial infarction was more (34%) in age group 50-59.
More than 60% patients suffering from acute myocardial infarction was age group 40-60 years. Presence of metabolic syndrome using ATPIII criteria of the study population is shown in The most prevalent component in female patients (Table 3 ) was low HDL-C (n 76; 73.8%), followed by fasting plasma glucose level (n 73; 70.9%). Next were high blood pressure (64.1%) then abdominal obesity (60.2%) and trigyceride (54.4%). Mean HDL-C (female 73.8% vs male 33%, p=.000) and fasting plasma glucose levels (female 70.9% vs male 56.3%, p=.000) were greater in women than in men. 
Discussion
Prevalence of Metabolic Syndrome:
The present study found that female patients with AMI had a high prevalence of MetS (71.8%). This percentage is not similar to that described in other populations with atherosclerotic vascular disease. In a previous Spanish study conducted with patients in secondary prevention, the prevalence of MetS was 41% when EGIR criteria were applied 19 . In general population studies conducted in the United States, the prevalence of MetS was 24% 7 whereas in a Spanish working population the prevalence was 10.2%-13.4% and was much higher in men than in women 20, 21 . The fact that the prevalence of MetS is higher in populations with ACS than in the general population demonstrates the association between MetS and ischemic heart disease. Although the prevalence of MetS is greater in men than in women in the general population 21 , our study suggests that MetS is more prevalent in women than in men (71.8% vs 37.9%, P<.001) which is similar to the results obtained in other populations with ischemic hear disease [22] [23] [24] [25] . This can be attributed, at least in part, to the fact that in the present study the women with AMI were older and presented a higher prevalence of low HDL-C (n 76, 73.8%; female 73.8% vs male 33%, p=.000 ), these results are consistent with those of other similar studies 26, 27 . In this study the HDL-C concentrations were higher in women; and there was a greater frequency of low HDL-C levels when ATPIII criteria were applied. Taking this into account, we can assume that MetS is more frequent in female patients and an important marker of cardiovascular risk among women.
Components of Metabolic Syndrome:
MetS increases cardiovascular risk and each of its components is associated with an increased risk of cardiovascular disease. In our cohort, hyperglycemia and low HDL-C levels were the most prevalent components of MetS, followed by hypertension. Residual risk of AMI depends to a great extent on low HDL-C levels. Multiple observational and prospective epidemiological studies have demonstrated that HDL-C concentrations are inversely and independently associated with the development of ischemic heart disease 28 . The ATPIII concluded that low HDLc concentrations and high triglyceride levels are cardiovascular risk factors, regardless of LDL-C levels. In this study low HDL-C levels (73.8%) and hyperglycemia (70.9%) were the most prevalent components of MetS, followed by hypertension (64.1%).
Conclusions
The present study shows a high prevalence of MetS in female patients with AMI. Women with AMI show a higher prevalence and a greater number of metabolic components than men. The most prevalent components of the MetS were low HDL-C concentrations and hypergycemia, followed by hypertension.
